Crossmark

Impact of Tumor Assessment Frequency on Statistical Power in Randomized Cancer Clinical Trials Evaluating Progression-Free Survival

Published Online: 2021-07-28

Published Print: 2021-11

Authors

Nakagawa, Yuki https://orcid.org/0000-0003-4103-2423
Yoshimoto, Takuya

Nakagawa, Shintaro

Sugitani, Yasuo

Yamamoto, Hideharu

Asakawa, Takashi
License Information

Text and Data Mining valid from 2021-07-28

Version of Record valid from 2021-07-28
More Information

Article History

Received: 19 March 2021

Accepted: 22 July 2021

First Online: 28 July 2021

Declarations

:

: All authors are employees of Chugai Pharmaceutical Co., Ltd.

Document is current